home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Cancer Stems From Early Stem Cells

 
  April, 7 2003 8:08
your information resource in human molecular genetics
 
     
Some late-life cancers may be due to defects that occur in early development, suggests a mathematical model of mutation patterns in tissues.

Many cancers, such as those of the skin and colon, arise in tissues that are constantly replenished with cells throughout life. But the crucial mutations that lead to the disease are most likely to have occurred during the tissues’ formative period, when cells are dividing exponentially.

Steven Frank of the University of California, Irvine, and Martin Nowak of the Institute for Advanced Study in Princeton, New Jersey, devised a model to track the number of defects spawned by mutations at different stages of tissue development (Nature, Vol. 422, No. 6931, p. 494, 03 April 2003). They calculate that the cancer risk from an early mutation may be 100% greater than that from a mutation that occurs during the replenishment phase.

This suggests that keeping babies shielded from the sun could indeed be a wise preventative measure against later skin cancer.

CONTACT:

Steven Frank
tel: +1 949 824 2244
e-mail: safrank@uci.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.